European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

GNFT

FR0004163111

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:35:55 2024-09-20 EDT			5-day change	1st Jan Change
4.310 ^EUR	+10.23%		+12.09%	+21.75%

09-20	European Equities Traded in the US as American Depositary Receipts Decrease Friday	MT
09-20	Genfit: net income of 30.3 ME in the first half of the year	CF

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Vous êtes déja client ? Log In

Latest news about GENFIT

European Equities Traded in the US as American Depositary Receipts Decrease Friday	09-20	MT
Genfit: net income of 30.3 ME in the first half of the year	09-20	CF
Genfit S.A. Reports Earnings Results for the Half Year Ended June 30, 2024	09-19	CI
European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading	09-17	MT
European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading	09-16	MT
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading	09-11	MT
European Equities Traded in the US as American Depositary Receipts Rise Sharply in Monday Trading	09-09	MT
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	09-06	MT
European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading	09-04	MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading	09-03	MT
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	08-28	MT
European Equities Traded in the US as American Depositary Receipts Trend Slightly Higher in Wednesday Trading	08-21	MT
European Equities Traded in the US as American Depositary Receipts Open Week Strong Monday Trading	08-19	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	08-13	MT
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading	08-12	MT
European Equities Traded in the US as American Depositary Receipts Climb Higher in Thursday Trading	08-08	MT
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading	08-07	MT
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading	08-06	MT
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Sharply Lower Thursday	08-01	MT
European Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading	07-30	MT
European Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading	07-29	MT
Genfit: positive CHMP opinion for Iqirvo to treat PBC	07-26	CF
European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading	07-24	MT
European Equities Traded in the US as American Depositary Receipts Move Lower in Tuesday Trading	07-23	MT
European Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading	07-22	MT

GENFIT is a biopharmaceutical company in late-stage development focused on the discovery and development of innovative therapeutic and diagnostic solutions in the field of liver diseases, particularly of metabolic origin, where unmet medical needs are considerable, in particular due to a lack of approved treatments. GENFIT is a leading innovator in the field of nuclear receptor-based drug discovery with a rich history and a solid scientific heritage spanning nearly two decades. The company has offices in Lille, Paris, Zurich and Cambridge, MA (USA).

Employees

159

Sector

Biotechnology & Medical Research

Calendar

2024-11-06 - Q3 2024 Sales and Revenue Release

More about the company